Read + Share
McGrail DJ, Pilie PG, Rashid NU, Voorwerk L, et al. Validation of cancer-type-dependent benefit from immune checkpoint blockade in
TMB-H tumors identified by the FoundationOne CDx assay. Ann Oncol 2022;33:1204-1206.
PMID: 35926816
|
 |
|
McGrail DJ, Pilie PG, Rashid NU, Voorwerk L, et al. Validation of cancer-type-dependent benefit from immune checkpoint blockade in
TMB-H tumors identified by the FoundationOne CDx assay. Ann Oncol 2022;33:1204-1206.
PMID: 35926816
|
|
|
|